Myasthenia gravis: the changing treatment landscape in the era of molecular therapies
Università Cattolica del Sacro Cuore
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
107
total citations
- FWCI
- 36.55
- Percentile
- 100%
- References
- 179
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Myasthenia gravis
- Acetylcholine receptor
- Medicine
- Monoclonal antibody
- Neuromuscular junction
- Antibody
- Muscle weakness
- Acetylcholinesterase
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.